A

Amboss

Evidence-based medical knowledge platform for clinicians

Business Growth Manager

Full-TimeUpdated on 10/15/2026
No salary listed
Mid
Bachelor's
Remote in Philippines
RemoteTravel to hospitals, clinics, conferences, and medical events across APAC is part of the role.
Sales & Account ManagementField Sales

About the job

Requirements
  • A licensed medical degree from an APAC country is required; clinical experience is ideal.
  • Excellent English is required to explain the product’s value to different audiences and present ideas clearly.
  • A structured, independent working style, with strong organization and time-management skills, is required.
  • The candidate must be able to dedicate full time, 40 hours per week.
  • The candidate should be willing to meet physicians and visit hospitals and clinics across APAC, as travel is part of the role.
Responsibilities
  • Identify APAC hospitals whose clinicians do not yet have an AMBOSS license and plan outreach with the team.
  • Grow partnerships from medical schools to affiliated teaching hospitals to support doctors from student years through residency and beyond.
  • Speak with active users, department heads, and hospital decision-makers; understand training and daily-practice needs and conduct needs analyses.
  • Tailor presentations to different audiences, including residents and medical education leads.
  • Connect clinicians with Customer Success, Sales Operations, and Marketing so clinician feedback informs products and offerings.
  • Plan local projects and events, such as teaching sessions and clinician meetups.
  • Support hospitals from initial conversations through rollout and maintain relationships after onboarding.
  • Work with the Data Team and Sales Operations to interpret usage data, identify where clinicians need support, and act on those findings.
  • Represent AMBOSS at conferences and medical events, and build the company’s network and brand awareness across the region.
Desired Qualifications
  • Fluency in a local language from Malaysia, Singapore, or the Philippines is a plus.
  • Clinical experience is ideal.

About the company

AMBOSS provides a medical knowledge platform used by students and clinicians. It combines an interactive library and high-yield question bank for students to study and prep for exams with a clinical decision support system for clinicians to guide patient care using evidence-based recommendations. The platform works online: users search and study from the medical library, practice with questions, and access point-of-care guidance and clinical decision support at the bedside or in clinics. AMBOSS differentiates itself through its physician-founded approach, a global team of physicians, scientists, and engineers, and its breadth of content that serves over a million healthcare professionals in 180+ countries, integrating both learning tools and real-time clinical guidance in one platform. The company aims to improve medical knowledge and clinical decision-making worldwide, helping physicians provide better patient care.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$302M

Headquarters

Berlin, Germany

Founded

2012

Get referred to Amboss

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AMBOSS launched AI Mode Learning in 2026, expanding daily usage beyond exam prep.
  • The March 2025 €240 million round funds international expansion and selective acquisitions.
  • August 2026 updates and global reach support product depth across 180 countries.

What critics are saying

  • OpenAI, Google, and Epic compress medical search into general-purpose copilots by 2027.
  • UpToDate and clinical AI vendors can undercut AMBOSS in hospital purchasing cycles.
  • If AMBOSS loses clinical-care relevance, it reverts to a student-only subscription business.

What makes Amboss unique

  • AMBOSS spans learning, clinical care, and teaching in one medical platform.
  • Its 2026 AI Mode pairs curated guidelines with inline citations and limits.
  • Physician-built content and 22,000+ questions create a trusted workflow moat.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Mental Health Support
  • Flexible Work Hours
  • Remote Work Options
  • Relocation Assistance

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
deutsche-startups.de
Jul 30th, 2025
Amboss Raises €240M, Valued at €800M

STARTUPLAND is set for November 5 at Cologne's RheinEnergieStadion, featuring talks, pitches, and networking. Key speakers include Sievert Weiss of Amboss, which raised €240 million at an €800 million valuation, and Shikha Ahluwalia from Balderton Capital, focusing on mental health. Sven Lackinger of Sastrify will discuss challenges in scaling. The event includes a pitch stage for young startups and is part of the RISE in STARTUPLAND-Week, turning Cologne into a startup hub.

Burda Principal Investments
May 13th, 2025
AMBOSS: Transforming Healthcare with AI Support

BPI has invested in AMBOSS, a platform evolving from a medical student tool to an AI-supported clinical companion for healthcare professionals. With over 1 million users globally, AMBOSS is expanding in the US and DACH regions. The company operates a hybrid B2C/B2B model, showing strong growth and profitability. AMBOSS is also expanding into new markets and roles, leveraging AI for reliable clinical decision-making. The investment supports AMBOSS's mission to enhance healthcare outcomes.

Handelsblatt
Apr 24th, 2025
Amboss Targets Global Expansion with Funding

Amboss, a medical learning platform, is aiming to become a market leader by raising significant funds, more than most healthtech startups. The new capital will also be used for acquisitions, with a key focus on expanding in the USA.

deutsche-startups.de
Apr 16th, 2025
Amboss secures €240M investment round

In Q1 2025, over €2.5 billion was invested in more than 40 startups. Notable investments include Finn, Amboss, and Solaris. Finn received up to €1 billion from Citi, Jefferies, and Avellinia Capital. Amboss secured €240 million from Kirkbi, M&G Investments, Lightrock, and existing investors, valuing the company at €800 million. Solaris attracted investment from SBI Group and Boerse Stuttgart Group.

deutsche-startups.de
Mar 25th, 2025
Amboss raises €240 million funding

Amboss has raised €240 million in a funding round led by Kirkbi, MG Investments, and Lightrock, with existing investors also participating. The Berlin-based EdTech company is now valued at approximately €800 million. The new capital will be used to expand into international markets and enhance offerings for healthcare professionals.